These emerging tools provide critical insights into tau pathology, enabling earlier detection and characterisation of disease‐relevant aggregates, thereby offering potential for the development of targeted therapies and diagnostic approaches for tauopathies. The gene discussed is MAPT; the disease is tauopathy.